IQV - IQVIA Holdings Inc. Stock Price and Quote

IQV [NYSE]

Healthcare | Diagnostics & Research | USA

Index	S&P 500	P/E	34.78	EPS (ttm)	5.72	Insider Own	0.88%	Shs Outstand	185.50M	Perf Week	5.60%
Market Cap	36.95B	Forward P/E	16.52	EPS next Y	12.04	Insider Trans	-0.33%	Shs Float	184.29M	Perf Month	-7.85%
Income	1.09B	PEG	3.00	EPS next Q	2.41	Inst Own	91.10%	Short Float / Ratio	0.95% / 1.77	Perf Quarter	-4.29%
Sales	14.41B	P/S	2.56	EPS this Y	15.50%	Inst Trans	0.41%	Short Interest	1.75M	Perf Half Y	9.51%
Book/sh	31.08	P/B	6.40	EPS next Y	15.40%	ROA	4.40%	Target Price	258.65	Perf Year	-14.02%
Cash/sh	7.05	P/C	28.23	EPS next 5Y	11.61%	ROE	19.50%	52W Range	165.75 - 254.94	Perf YTD	-2.93%
Dividend	-	P/FCF	23.30	EPS past 5Y	32.60%	ROI	8.20%	52W High	-21.99%	Beta	1.42
Dividend %	-	Quick Ratio	0.90	Sales past 5Y	8.20%	Gross Margin	34.90%	52W Low	19.99%	ATR	5.76
Employees	86000	Current Ratio	0.90	Sales Q/Q	2.80%	Oper. Margin	12.50%	RSI (14)	47.79	Volatility	1.63% 3.02%
Optionable	Yes	Debt/Eq	2.21	EPS Q/Q	-26.20%	Profit Margin	7.60%	Rel Volume	0.98	Prev Close	194.95
Shortable	Yes	LT Debt/Eq	2.18	Earnings	Feb 10 BMO	Payout	0.00%	Avg Volume	983.62K	Price	198.89
Recom	1.70	SMA20	0.20%	SMA50	-7.05%	SMA200	-6.03%	Volume	962,864	Change	2.02%

Mar-17-23

Initiated

Truist

Buy

$265

Dec-06-22

Initiated

Cowen

Outperform

$251

Nov-17-22

Downgrade

Citigroup

Buy → Neutral

$275 → $245

Aug-25-22

Initiated

Credit Suisse

Outperform

$300

Jul-15-22

Initiated

SVB Leerink

Outperform

$256

May-24-22

Initiated

Guggenheim

Buy

$244

Apr-29-22

Upgrade

Piper Sandler

Neutral → Overweight

$231 → $255

Apr-25-22

Downgrade

Wells Fargo

Overweight → Equal Weight

$235

Aug-05-21

Resumed

Credit Suisse

Outperform

$272

Apr-16-21

Upgrade

Stephens

Equal-Weight → Overweight

$180 → $250

Show Previous Ratings

Mar-28-23 12:56PM	Analyst Report: IQVIA Holdings Inc Argus Research
12:41PM	Market Update: KO, IQV Argus Research
Mar-25-23 07:20AM	2 Clinical Research Stocks That Could Grow by More Than 10% This Year, and 1 to Watch Motley Fool
Mar-14-23 08:00AM	Global Clinical Trial Activity Remained Resilient in 2022 Despite The Continued Pandemic, Says IQVIA Institute Business Wire
Mar-13-23 02:39PM	IQVIA Holdings (NYSE:IQV) sheds 10% this week, as yearly returns fall more in line with earnings growth Simply Wall St.
08:29PM	Loading…
Mar-02-23 08:29PM	Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q4 2022 Earnings Call Transcript Insider Monkey
Mar-01-23 04:15PM	IQVIA CFO Ron Bruehlman to Speak at Barclays Global Healthcare Conference on March 15, 2023 Business Wire
Feb-27-23 12:51PM	Should You Be Excited About IQVIA Holdings Inc.'s (NYSE:IQV) 19% Return On Equity? Simply Wall St.
07:56AM	Weekly Stock List Argus Research
Feb-23-23 11:00AM	IQVIA Publishes its 2022 Environmental, Social and Governance Report Business Wire
Feb-21-23 06:48PM	Biosimilars Were Supposed to Tame Costs for Drugs Like Humira. It Isnt Working. Barrons.com
05:16AM	Got $300? 3 Growth Stocks to Buy That Could Double Your Money Motley Fool
Feb-16-23 02:45PM	Iqvia leaves prominent Durham tower American City Business Journals
Feb-15-23 02:11PM	7 Hot Healthcare Stocks With the Potential to Outperform InvestorPlace
Feb-13-23 02:34PM	Analyst Report: IQVIA Holdings Inc. Morningstar Research
11:43AM	Loading…
11:43AM	Fidelity National (FIS) Q4 Earnings Beat on Banking Business Zacks
Feb-12-23 07:35AM	IQVIA Holdings Full Year 2022 Earnings: EPS Misses Expectations Simply Wall St.
Feb-10-23 11:32AM	IQVIA (IQV) Q4 Earnings and Revenues Beat Mark, Rise Y/Y Zacks
08:59AM	IQVIA Clocks 2.8% Sales Growth In Q4, Beats Street View By A Whisker Benzinga
08:25AM	IQVIA Holdings (IQV) Beats Q4 Earnings and Revenue Estimates Zacks
07:00AM	IQVIA Reports Fourth-Quarter and Full-Year 2022 Results; Issues Full-Year 2023 Guidance Business Wire
Feb-09-23 12:00PM	IQVIA Named to FORTUNEs 2023 List of "Worlds Most Admired Companies," Ranked #1 in Its Category for the Second Consecutive Year Business Wire
Feb-07-23 09:53AM	3 Revolutionary Stocks I'd Buy Right Now Without Hesitation Motley Fool
Feb-06-23 01:34PM	IQVIA (IQV) to Report Q4 Earnings: What's in the Cards? Zacks
Feb-03-23 10:00AM	IQVIA Holdings (IQV) Earnings Expected to Grow: Should You Buy? Zacks
08:35AM	At US$241, Is IQVIA Holdings Inc. (NYSE:IQV) Worth Looking At Closely? Simply Wall St.
Jan-31-23 09:59AM	IQVIA in Collaboration with Alibaba Cloud to Deliver Commercial & Clinical Solutions in China Business Wire
Jan-30-23 05:25PM	Symbotic Inc. (SYM) Reports Q1 Loss, Tops Revenue Estimates Zacks
Jan-25-23 05:35PM	Seagate (STX) Q2 Earnings and Revenues Surpass Estimates Zacks
04:15PM	IQVIA to Announce Fourth-Quarter and Full-Year 2022 Results on February 10, 2023 Business Wire
08:25AM	Loading…
Jan-20-23 08:25AM	Here's Why IQVIA Holdings (NYSE:IQV) Has Caught The Eye Of Investors Simply Wall St.
Jan-18-23 12:26PM	Global Market for Medicines to Rise to $1.9 Trillion by 2027, says Report from IQVIA Institute Business Wire
Jan-11-23 08:44AM	2 Unstoppable Growth Stocks to Buy in 2023 and Beyond Motley Fool
07:39AM	Judge rules Iqvia's noncompete lawsuit can continue as FTC pushes ban American City Business Journals
Jan-06-23 07:00AM	IQVIA Holdings Inc. (NYSE:IQV) is largely controlled by institutional shareholders who own 89% of the company Simply Wall St.
05:51AM	IQVIA (IQV) Gains 10.4% in the Past 3 Months: Here's Why Zacks
Jan-05-23 02:08PM	Labcorp names Thomas Pike as president and CEO of clinical development business spin-off American City Business Journals
02:27AM	Instructure (INST) Surges 7.9%: Is This an Indication of Further Gains? Zacks
Jan-03-23 11:05AM	Lasso announces a significant step forward in healthcare marketing measurement PR Newswire
Jan-02-23 07:34AM	Is IQVIA Holdings Inc. (NYSE:IQV) Trading At A 27% Discount? Simply Wall St.
Dec-28-22 08:30AM	Biostage Selects IQVIA to Manage its FDA-Approved Clinical Trial in Severe Esophageal Disease, including Cancer PR Newswire
Dec-20-22 09:45AM	Why IQVIA Holdings (IQV) is a Top Growth Stock for the Long-Term Zacks
Dec-08-22 02:13PM	Do You Think IQVIA Holdings (IQV) is a Worthy Investment? Insider Monkey
11:31AM	Why Is ADTRAN Holdings (ADTN) Up 4.7% Since Last Earnings Report? Zacks
Dec-02-22 11:31AM	Why Is Trane Technologies (TT) Up 8.1% Since Last Earnings Report? Zacks
Nov-25-22 11:31AM	Why Is IQVIA (IQV) Up 8.6% Since Last Earnings Report? Zacks
Nov-14-22 07:19AM	Zacks Industry Outlook Highlights IQVIA Holdings, Matterport and TuSimple Holdings Zacks
Nov-11-22 11:47AM	3 Technology Services Stocks to Watch From a Promising Industry Zacks
Nov-10-22 11:00AM	IQVIA and Clalit Health Services partner to advance research by launching the first Prime Site in Israel Business Wire +8.94%
Oct-27-22 02:49PM	Mastercard's (MA) Q3 Earnings Beat Estimates on Better GDV Zacks
Oct-26-22 03:25PM	IQVIA (IQV) Q3 Earnings and Revenues Beat Mark, Rise Y/Y Zacks
08:25AM	IQVIA Holdings (IQV) Q3 Earnings and Revenues Top Estimates Zacks
07:00AM	IQVIA Reports Third-Quarter 2022 Results Business Wire
Oct-24-22 04:15PM	IQVIA CFO Ron Bruehlman to Speak at Credit Suisse Annual Healthcare Conference on November 8, 2022 Business Wire
Oct-20-22 02:12PM	IQVIA (IQV) to Report Q3 Earnings: What's in the Cards? Zacks
Oct-19-22 10:01AM	IQVIA Holdings (IQV) Earnings Expected to Grow: Should You Buy? Zacks
Oct-18-22 01:01PM	With 89% ownership of the shares, IQVIA Holdings Inc. (NYSE:IQV) is heavily dominated by institutional owners Simply Wall St.
Oct-12-22 07:22AM	Here's Why You Should Invest in IQVIA Holdings (IQV) Now Zacks
Oct-11-22 02:45PM	Mastercard's (MA) Platform to Simplify Global Business Payments Zacks
09:35AM	IQVIA (IQV) Loses 22.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner Zacks
Oct-10-22 11:40AM	IQV vs. CLBT: Which Stock Is the Better Value Option? Zacks
09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick Zacks
Oct-07-22 09:01AM	10 Best Fast Money Stocks To Buy According To Hedge Funds Insider Monkey
Oct-06-22 08:15AM	Q² Solutions Launches Innovative Self-Collection Safety Lab Panel in Collaboration With Tasso Business Wire
Oct-04-22 11:46AM	Those who invested in IQVIA Holdings (NYSE:IQV) five years ago are up 94% Simply Wall St.
Oct-03-22 04:15PM	IQVIA to Announce Third-Quarter 2022 Results on October 26, 2022 Business Wire
Sep-30-22 03:07PM	Durham giant Iqvia drops one lawsuit against ex-VP while another continues American City Business Journals
Sep-28-22 10:00AM	IQVIA Decentralized Clinical Trial Program Achieves Independent GDPR Validation Business Wire
Sep-23-22 05:12PM	Paychex (PAYX) to Report Q1 Earnings: What's in the Cards? Zacks
09:41AM	10 Best Stocks to Buy Now According to Billionaire Thomas Steyer Insider Monkey
Sep-22-22 08:05AM	Accenture (ACN) Beats Q4 Earnings Estimates Zacks
Sep-20-22 04:31PM	What's in the Offing for Accenture (ACN) in Q4 Earnings? Zacks
02:30PM	How Raleigh, Triangle lost its most prominent public companies American City Business Journals
11:30AM	Is IQVIA Holdings Inc.'s (NYSE:IQV) ROE Of 22% Impressive? Simply Wall St.
Sep-19-22 10:06AM	FactSet (FDS) to Report Q4 Earnings: What's in the Offing? Zacks
Sep-16-22 05:59PM	Here's Why a Hold Strategy is Apt for IQVIA (IQV) Stock Zacks
Sep-07-22 08:15AM	New IQVIA Study Demonstrates Cost and Time Savings of Decentralized Trials Business Wire
Sep-06-22 10:36AM	Insiders who placed huge bets on IQVIA Holdings Inc. (NYSE:IQV) earlier this year would be disappointed with the 5.0% drop Simply Wall St.
Sep-05-22 08:35AM	DocuSign (DOCU) to Report Q2 Earnings: What's in the Offing? Zacks
Sep-02-22 03:16PM	UiPath (PATH) to Report Q2 Earnings: What's in the Offing? Zacks
08:15AM	IQVIA CEO Ari Bousbib to Speak at Baird Global Healthcare Conference on September 14, 2022 Business Wire
Sep-01-22 04:15PM	IQVIA CFO Ron Bruehlman to Speak at Morgan Stanley Annual Global Healthcare Conference on September 13, 2022 Business Wire
Aug-29-22 07:14PM	10 Best Biotech Stocks To Buy Now Insider Monkey
Aug-23-22 10:00AM	At US$232, Is IQVIA Holdings Inc. (NYSE:IQV) Worth Looking At Closely? Simply Wall St.
Aug-15-22 07:30AM	IQVIA Wins Snowflakes "Marketplace Healthcare and Life Sciences Partner of the Year" Award Business Wire
04:59AM	Reasons to Retain IQVIA Holdings (IQV) Stock in Your Portfolio Zacks
Aug-12-22 11:56AM	Broadridge's (BR) Q4 Earnings Match Estimates, Up Y/Y Zacks
Aug-11-22 02:51PM	Green Dot (GDOT) Stock Down 16.2% Despite Q2 Earnings Beat Zacks
01:12PM	Is a Beat in the Cards for Broadridge (BR) in Q4 Earnings? Zacks
Aug-10-22 02:18PM	Genpact's (G) Stock Slips 2.3% Despite Q2 Earnings Beat Zacks
09:13AM	H&R Block's (HRB) Q4 Earnings Beat Estimates, Increase YoY Zacks
Aug-09-22 03:19PM	Charles River (CRAI) Stock Drops 9.8% Despite Q2 Earnings Beat Zacks
09:05AM	Should You Be Adding IQVIA Holdings (NYSE:IQV) To Your Watchlist Today? Simply Wall St.
Aug-08-22 08:06AM	New York firm tries to squash Iqvia's lawsuit over former VP American City Business Journals
Aug-04-22 11:50AM	Aptiv's (APTV) Q2 Earnings Miss Estimates, Decline Y/Y Zacks
Aug-03-22 11:32AM	Trane Technologies (TT) Q2 Earnings Beat Estimates, Up Y/Y Zacks
Aug-02-22 02:40PM	Gartner (IT) Q2 Earnings Beat Estimates, 2022 EPS Guidance Up Zacks
01:58PM	Avis Budget Group (CAR) Q2 Earnings Beat Mark, Increase Y/Y Zacks
Jul-27-22 03:32PM	Automatic Data Processing (ADP) Q4 Earnings Beat, Surge Y/Y Zacks
12:54PM	Rollins' (ROL) Q2 Earnings Meet Estimates, Revenues Beat Zacks

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and decentralized clinical trials, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was incorporated in 2016 and is headquartered in Durham, North Carolina.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Knightly Kevin C	See Remarks	Feb 16	Sale	225.61	4,446	1,003,068	1,973	Feb 17 05:13 PM
Sherbet Eric	See Remarks	Feb 14	Sale	230.00	1,000	230,000	17,053	Feb 15 05:58 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Upgrade your FINVIZ experience